Kester Capital backs Frontier Medical
10 December 2013
Kester Capital LLP (“Kester Capital”) is pleased to announce its investment in Frontier Medical Products Limited (“Frontier”).
The Frontier management team, led by Nick Davis and Nigel Harris, have reinvested alongside Kester Capital and the transaction has been supported by new loan facilities from The Royal Bank of Scotland plc (“RBS”).
Founded in 1966, Frontier has grown to become a leading manufacturer and supplier of pressure area care and infection control products to healthcare providers in the UK and continental Europe. Frontier’s portfolio of highly regarded brands includes: Repose, a differentiated range of pressure area care devices; Sharpsafe, premium quality sharps disposal containers; and eXchange, specialist harm reduction products and services. Frontier is based in Blackwood, Wales, and employs over 250 people.
Nick Davis, Managing Director at Frontier, said: “We are pleased to have secured Kester Capital’s support for our continued growth plans. The investment is testament to the strength of the business and we look forward to capitalising on the growing market opportunity and the foundation we have built over the last 40 years. We are also pleased to be continuing our long standing relationship with RBS.”
Cameron Crockett, Partner at Kester Capital said: “Frontier is a good example of the type of business that Kester Capital looks to back. Pressure area care and infection control have emerged as areas of serious concern for healthcare providers across the world and Frontier has an enviable track record of helping its customers deal with these growing issues both in the UK and overseas.”
RBS provided term and ancillary facilities for the transaction. Commenting, Nick Evans, Director at RBS, said: “We are very pleased to have been able to support this transaction and continue our relationship with Frontier, a strong local business that we have worked with since 1973.”
Kester Capital was advised by CIL, Grant Thornton and Travers Smith.
Frontier was advised by EY and Meade King.
RBS was advised by Osborne Clarke.
For further enquiries please contact:
Kester Capital LLP
+44 (0) 203 747 5700
Frontier Medical Products Limited
+44 (0) 1495 235 839
About Kester Capital LLP
Kester Capital was established in 2007 as Greenhill Capital Partners Europe (“GCP Europe”), the European private equity arm of Greenhill & Co Inc. Kester Capital is currently investing its second fund, which was raised in early 2013, targeting equity investments of £5 – 25 million.